Basel Medical Group Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 23, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Cap	11	33	-	-	-
Market Cap Growth	-85.23%	-	-	-	-
Enterprise Value	8.34	35.01	0	0	0
Last Close Price	6.95	1.78	-	-	-
PS Ratio	1.23	3.75	-	-	-
PB Ratio	2.72	7.81	-	-	-
P/TBV Ratio	24.01	6.15	-	-	-
EV/Sales Ratio	0.94	3.93	-	-	-
Debt / Equity Ratio	0.54	0.54	0.21	0.62	1.61
Debt / EBITDA Ratio	-	-	1.62	2.87	3.72
Debt / FCF Ratio	-	-	1.72	2.78	3.76
Net Debt / Equity Ratio	0.37	0.37	0.31	1.09	2.32
Net Debt / EBITDA Ratio	-0.18	-0.18	0.88	2.38	3.15
Net Debt / FCF Ratio	-0.44	-0.44	0.94	2.31	3.18
Asset Turnover	0.67	0.65	0.63	0.60	0.63
Inventory Turnover	30.42	31.90	70.66	67.92	88.93
Quick Ratio	1.23	1.23	2.03	2.27	2.17
Current Ratio	1.31	1.31	2.26	2.28	2.18
Return on Equity (ROE)	-167.50%	-163.64%	31.77%	38.79%	64.40%
Return on Assets (ROA)	-72.15%	-69.32%	11.53%	12.15%	12.78%
Return on Invested Capital (ROIC)	-162.28%	-118.89%	16.00%	16.33%	17.25%
Return on Capital Employed (ROCE)	-159.72%	-142.69%	23.48%	21.09%	22.30%
Buyback Yield / Dilution	-15.60%	-15.60%	0.00%	0.00%	-
Total Shareholder Return	-15.60%	-15.60%	0.00%	0.00%	-

SEC Filings: 10-K · 10-Q